Description
EPM2A Polyclonal Antibody | E-AB-18758 | Gentaur UK, US & Europe Distribution
Type: Polyclonal Antibody
Synonyms: Epilepsy progressive myoclonus type 2 Lafora disease (laforin), Epilepsy progressive myoclonus type 2A Lafora disease (laforin), EPM2, Epm2a, Epm2a gene, EPM2A, Lafora PTPase, Laforin, LAFPTPase, LD, LDE, MELF, RP3-466P17.2
Application: IHC, ELISA
Reactivity: Human, Mouse, Rat
Host: Rabbit
Isotype: IgG
Reserch Areas: Metabolism, Signal transduction
Background: This gene encodes a dual-specificity phosphatase that associates with polyribosomes. The encoded protein may be involved in the regulation of glycogen metabolism. Mutations in this gene have been associated with myoclonic epilepsy of Lafora. Alternative splicing results in multiple transcript variants.
Concentration: 0.96 mg/mL
Storage: Store at -20°C. Avoid freeze / thaw cycles.
Immunogen: Fusion protein of human EPM2A
Buffer: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Purification Method: Antigen affinity purification
Dilution: IHC 1:50-1:300, ELISA 1:5000-1:10000
Clone: N/A
Conjugation: Unconjugated
Molecular Weight(Calculated): N/A
Molecular Weight(Observed): N/A